Colgate-Palmolive’s premium strategy and pet nutrition expansion drive growth, with a $115 target signaling 26% upside. Read more about CL stock here.
JPMorgan analyst Andrea Teixeira raised the firm’s price target on Colgate-Palmolive (CL) to $99 from $97 and keeps an Overweight rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results